Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 226

1.

A 52-Year-Old Woman With an Abdominal Mass, Bilateral Pulmonary Nodules, and Mediastinal and Hilar Lymphadenopathy.

Van Treeck BJ, Gehlbach DA, Foster GH, Utz JP, Aubry MC, Colby TV, Yi ES.

Chest. 2019 Jun;155(6):e175-e178. doi: 10.1016/j.chest.2019.01.017.

PMID:
31174663
2.

Using genomics to differentiate multiple primaries from metastatic lung cancer.

Murphy SJ, Harris FR, Kosari F, Terra S, Nasir A, Johnson SH, Serla V, Smadbeck JB, Halling GC, Karagouga G, Sukov B, Leventakos K, Yang P, Peikert T, Mansfield AS, Wigle DA, Yi ES, Kipp BR, Vasmatzis G, Aubry MC.

J Thorac Oncol. 2019 May 16. pii: S1556-0864(19)30374-0. doi: 10.1016/j.jtho.2019.05.008. [Epub ahead of print]

3.

Immune Cell Infiltration May be a Key Determinant of Long-Term Survival in Small Cell Lung Cancer.

Muppa P, Parrilha Terra SB, Sharma A, Mansfield AS, Aubry MC, Bhinge K, Asiedu MK, de Andrade M, Janaki N, Murphy SJ, Nasir A, Van Keulen V, Vasmatzis G, Wigle DA, Yang P, Yi ES, Peikert T, Kosari F.

J Thorac Oncol. 2019 May 9. pii: S1556-0864(19)30356-9. doi: 10.1016/j.jtho.2019.03.028. [Epub ahead of print]

4.

A Case of IgG4-Related Aortitis and Pericarditis: Diagnostic Challenges and Natural History.

Weiss MA, Aubry MC, Pflederer BR.

Am J Case Rep. 2018 Oct 16;19:1232-1236. doi: 10.12659/AJCR.910164.

5.

Neoantigenic Potential of Complex Chromosomal Rearrangements in Mesothelioma.

Mansfield AS, Peikert T, Smadbeck JB, Udell JBM, Garcia-Rivera E, Elsbernd L, Erskine CL, Van Keulen VP, Kosari F, Murphy SJ, Ren H, Serla VV, Schaefer Klein JL, Karagouga G, Harris FR, Sosa C, Johnson SH, Nevala W, Markovic SN, Bungum AO, Edell ES, Dong H, Cheville JC, Aubry MC, Jen J, Vasmatzis G.

J Thorac Oncol. 2019 Feb;14(2):276-287. doi: 10.1016/j.jtho.2018.10.001. Epub 2018 Oct 10.

6.

Comparison of Programmed Death Ligand-1 Immunohistochemical Staining Between Endobronchial Ultrasound Transbronchial Needle Aspiration and Resected Lung Cancer Specimens.

Sakata KK, Midthun DE, Mullon JJ, Kern RM, Nelson DR, Edell ES, Schiavo DN, Jett JR, Aubry MC.

Chest. 2018 Oct;154(4):827-837. doi: 10.1016/j.chest.2018.07.017. Epub 2018 Jul 27.

PMID:
30059678
7.

Comparison of Risk Stratification Models to Predict Recurrence and Survival in Pleuropulmonary Solitary Fibrous Tumor.

Reisenauer JS, Mneimneh W, Jenkins S, Mansfield AS, Aubry MC, Fritchie KJ, Allen MS, Blackmon SH, Cassivi SD, Nichols FC, Wigle DA, Shen KR, Boland JM.

J Thorac Oncol. 2018 Sep;13(9):1349-1362. doi: 10.1016/j.jtho.2018.05.040. Epub 2018 Jun 20.

PMID:
29935303
8.

Contraction of T cell richness in lung cancer brain metastases.

Mansfield AS, Ren H, Sutor S, Sarangi V, Nair A, Davila J, Elsbernd LR, Udell JB, Dronca RS, Park S, Markovic SN, Sun Z, Halling KC, Nevala WK, Aubry MC, Dong H, Jen J.

Sci Rep. 2018 Feb 1;8(1):2171. doi: 10.1038/s41598-018-20622-8.

9.

Pathways Impacted by Genomic Alterations in Pulmonary Carcinoid Tumors.

Asiedu MK, Thomas CF Jr, Dong J, Schulte SC, Khadka P, Sun Z, Kosari F, Jen J, Molina J, Vasmatzis G, Kuang R, Aubry MC, Yang P, Wigle DA.

Clin Cancer Res. 2018 Apr 1;24(7):1691-1704. doi: 10.1158/1078-0432.CCR-17-0252. Epub 2018 Jan 19.

10.

Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.

Xie D, Allen MS, Marks R, Jiang G, Sun Z, Nichols F, Zhang M, Chen C, Aubry MC, Jatoi A, Garces YI, Mansfield A, Wigle D, Molina J, Deschamps C, Yang P.

Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1214-1222. doi: 10.1093/ejcts/ezx462.

11.

Computer-Aided Nodule Assessment and Risk Yield (CANARY) may facilitate non-invasive prediction of EGFR mutation status in lung adenocarcinomas.

Clay R, Kipp BR, Jenkins S, Karwoski RA, Maldonado F, Rajagopalan S, Voss JS, Bartholmai BJ, Aubry MC, Peikert T.

Sci Rep. 2017 Dec 15;7(1):17620. doi: 10.1038/s41598-017-17659-6.

12.

Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma.

Pillappa R, Maleszewski JJ, Sukov WR, Bedroske PP, Greipp PT, Boland JM, Yi ES, Peikert T, Aubry MC, Roden AC.

Am J Surg Pathol. 2018 Feb;42(2):256-263. doi: 10.1097/PAS.0000000000000976.

PMID:
29076876
13.

Patient- and Cell Type-Specific Heterogeneity of Metformin Response.

Asiedu MK, Barron M, Aubry MC, Wigle DA.

Basic Clin Pharmacol Toxicol. 2018 Feb;122(2):214-222. doi: 10.1111/bcpt.12898. Epub 2017 Sep 19.

14.

Local and systemic immunity predict survival in patients with pulmonary sarcomatoid carcinoma.

Schenk E, Boland J, Mansfield A, Aubry MC, Dietz A.

Med Oncol. 2017 Aug;34(8):140. doi: 10.1007/s12032-017-1000-8. Epub 2017 Jul 15.

PMID:
28711968
15.

Histopathology of viral infections of the lung.

Pritt BS, Aubry MC.

Semin Diagn Pathol. 2017 Nov;34(6):510-517. doi: 10.1053/j.semdp.2017.06.005. Epub 2017 Jun 7. Review. No abstract available.

PMID:
28693907
16.

Management of Multifocal Lung Cancer: Results of a Survey.

Leventakos K, Peikert T, Midthun DE, Molina JR, Blackmon S, Nichols FC, Garces YI, Hallemeier CL, Murphy SJ, Vasmatzis G, Kratz SL, Holland WP, Thomas CF, Mullon JJ, Shen KR, Cassivi SD, Marks RS, Aubry MC, Adjei AA, Yang P, Allen MS, Edell ES, Wigle D, Mansfield AS.

J Thorac Oncol. 2017 Sep;12(9):1398-1402. doi: 10.1016/j.jtho.2017.05.013. Epub 2017 Jun 3.

17.

EGFR mediates activation of RET in lung adenocarcinoma with neuroendocrine differentiation characterized by ASCL1 expression.

Bhinge K, Yang L, Terra S, Nasir A, Muppa P, Aubry MC, Yi J, Janaki N, Kovtun IV, Murphy SJ, Halling G, Rahi H, Mansfield A, de Andrade M, Yang P, Vasmatzis G, Peikert T, Kosari F.

Oncotarget. 2017 Apr 18;8(16):27155-27165. doi: 10.18632/oncotarget.15676.

18.

Successful pacemaker lead extraction involving an ossified thrombus: A case report.

Okamura H, Van Arnam JS, Aubry MC, Friedman PA, Cha YM.

J Arrhythm. 2017 Apr;33(2):150-151. doi: 10.1016/j.joa.2016.06.007. Epub 2016 Aug 30.

19.

Cellular senescence mediates fibrotic pulmonary disease.

Schafer MJ, White TA, Iijima K, Haak AJ, Ligresti G, Atkinson EJ, Oberg AL, Birch J, Salmonowicz H, Zhu Y, Mazula DL, Brooks RW, Fuhrmann-Stroissnigg H, Pirtskhalava T, Prakash YS, Tchkonia T, Robbins PD, Aubry MC, Passos JF, Kirkland JL, Tschumperlin DJ, Kita H, LeBrasseur NK.

Nat Commun. 2017 Feb 23;8:14532. doi: 10.1038/ncomms14532.

20.

Loss of p16INK4A Expression and Homozygous CDKN2A Deletion Are Associated with Worse Outcome and Younger Age in Thymic Carcinomas.

Aesif SW, Aubry MC, Yi ES, Kloft-Nelson SM, Jenkins SM, Spears GM, Greipp PT, Sukov WR, Roden AC.

J Thorac Oncol. 2017 May;12(5):860-871. doi: 10.1016/j.jtho.2017.01.028. Epub 2017 Feb 5.

21.

Ixazomib cardiotoxicity: A possible class effect of proteasome inhibitors.

Jouni H, Aubry MC, Lacy MQ, Vincent Rajkumar S, Kumar SK, Frye RL, Herrmann J.

Am J Hematol. 2017 Feb;92(2):220-221. doi: 10.1002/ajh.24608. No abstract available.

22.

Diagnosis of Acute Cellular Rejection and Antibody-Mediated Rejection on Lung Transplant Biopsies: A Perspective From Members of the Pulmonary Pathology Society.

Roden AC, Aisner DL, Allen TC, Aubry MC, Barrios RJ, Beasley MB, Cagle PT, Capelozzi VL, Dacic S, Ge Y, Hariri LP, Lantuejoul S, Miller RA, Mino-Kenudson M, Moreira AL, Raparia K, Rekhtman N, Sholl L, Smith ML, Tsao MS, Vivero M, Yatabe Y, Yi ES.

Arch Pathol Lab Med. 2017 Mar;141(3):437-444. doi: 10.5858/arpa.2016-0459-SA. Epub 2016 Nov 7.

PMID:
27819763
23.

Think of the Conus Medullaris at the Time of Diagnosis of Fetal Sacral Agenesis.

Mottet N, Martinovic J, Baeza C, Guimiot F, Bault JP, Aubry MC, Riethmuller D, Zerah M, Cretolle C, Benachi A.

Fetal Diagn Ther. 2017;42(2):137-143. doi: 10.1159/000451080. Epub 2016 Oct 29.

PMID:
27794580
24.

Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors.

Johnson GB, Aubry MC, Yi ES, Koo CW, Jenkins SM, Garces YI, Marks RS, Cassivi SD, Roden AC.

J Thorac Oncol. 2017 Feb;12(2):354-367. doi: 10.1016/j.jtho.2016.09.118. Epub 2016 Sep 22.

25.

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

Lam S, Mandrekar SJ, Gesthalter Y, Allen Ziegler KL, Seisler DK, Midthun DE, Mao JT, Aubry MC, McWilliams A, Sin DD, Shaipanich T, Liu G, Johnson E, Bild A, Lenburg ME, Ionescu DN, Mayo J, Yi JE, Tazelaar H, Harmsen WS, Smith J, Spira AE, Beane J, Limburg PJ, Szabo E; Cancer Prevention Network.

Cancer Prev Res (Phila). 2016 Dec;9(12):906-914. Epub 2016 Sep 22.

26.

Primary angiomatoid fibrous histiocytoma of the lung with mediastinal lymph node metastasis.

Tay CK, Koh MS, Takano A, Aubry MC, Sukov WR, Folpe AL.

Hum Pathol. 2016 Dec;58:134-137. doi: 10.1016/j.humpath.2016.07.022. Epub 2016 Aug 18.

PMID:
27544801
27.

Temporal and spatial discordance of programmed cell death-ligand 1 expression and lymphocyte tumor infiltration between paired primary lesions and brain metastases in lung cancer.

Mansfield AS, Aubry MC, Moser JC, Harrington SM, Dronca RS, Park SS, Dong H.

Ann Oncol. 2016 Oct;27(10):1953-8. doi: 10.1093/annonc/mdw289. Epub 2016 Aug 8.

28.

Ciliated Muconodular Papillary Tumors of the Lung Can Occur in Western Patients and Show Mutations in BRAF and AKT1.

Liu L, Aesif SW, Kipp BR, Voss JS, Daniel S, Aubry MC, Boland JM.

Am J Surg Pathol. 2016 Dec;40(12):1631-1636.

PMID:
27454941
29.

Multiple-level validation identifies PARK2 in the development of lung cancer and chronic obstructive pulmonary disease.

Lee S, She J, Deng B, Kim J, de Andrade M, Na J, Sun Z, Wampfler JA, Cunningham JM, Wu Y, Limper AH, Aubry MC, Wendt C, Biterman P, Yang P, Lou Z.

Oncotarget. 2016 Jul 12;7(28):44211-44223. doi: 10.18632/oncotarget.9954.

30.

Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.

Boland JM, Froemming AT, Wampfler JA, Maldonado F, Peikert T, Hyland C, de Andrade M, Aubry MC, Yang P, Yi ES.

Hum Pathol. 2016 May;51:41-50. doi: 10.1016/j.humpath.2015.12.010. Epub 2015 Dec 30.

PMID:
27067781
31.

Ciliated muconodular papillary tumor: a solitary peripheral lung nodule in a teenage girl.

Lau KW, Aubry MC, Tan GS, Lim CH, Takano AM.

Hum Pathol. 2016 Mar;49:22-6. doi: 10.1016/j.humpath.2015.09.038. Epub 2015 Oct 28.

PMID:
26826405
32.

Heterogeneity of Programmed Cell Death Ligand 1 Expression in Multifocal Lung Cancer.

Mansfield AS, Murphy SJ, Peikert T, Yi ES, Vasmatzis G, Wigle DA, Aubry MC.

Clin Cancer Res. 2016 May 1;22(9):2177-82. doi: 10.1158/1078-0432.CCR-15-2246. Epub 2015 Dec 14.

33.

Transbronchial Cryobiopsies in the Evaluation of Lung Allografts: Do the Benefits Outweigh the Risks?

Roden AC, Kern RM, Aubry MC, Jenkins SM, Yi ES, Scott JP, Maldonado F.

Arch Pathol Lab Med. 2016 Apr;140(4):303-11. doi: 10.5858/arpa.2015-0294-OA. Epub 2015 Oct 21.

PMID:
26488148
34.

Detection of human papillomavirus in non-small cell carcinoma of the lung.

Chang SY, Keeney M, Law M, Donovan J, Aubry MC, Garcia J.

Hum Pathol. 2015 Nov;46(11):1592-7. doi: 10.1016/j.humpath.2015.07.012. Epub 2015 Jul 29.

PMID:
26342243
35.

Histopathologic and Cytogenetic Features of Pulmonary Adenoid Cystic Carcinoma.

Roden AC, Greipp PT, Knutson DL, Kloft-Nelson SM, Jenkins SM, Marks RS, Aubry MC, García JJ.

J Thorac Oncol. 2015 Nov;10(11):1570-5. doi: 10.1097/JTO.0000000000000656.

36.

Common Oncogene Mutations and Novel SND1-BRAF Transcript Fusion in Lung Adenocarcinoma from Never Smokers.

Jang JS, Lee A, Li J, Liyanage H, Yang Y, Guo L, Asmann YW, Li PW, Erickson-Johnson M, Sakai Y, Sun Z, Jeon HS, Hwang H, Bungum AO, Edell ES, Simon VA, Kopp KJ, Eckloff B, Oliveira AM, Wieben E, Aubry MC, Yi E, Wigle D, Diasio RB, Yang P, Jen J.

Sci Rep. 2015 May 18;5:9755. doi: 10.1038/srep09755.

37.

Prenatal diagnosis of Pierre Robin Sequence: accuracy and ability to predict phenotype and functional severity.

Lind K, Aubry MC, Belarbi N, Chalouhi C, Couly G, Benachi A, Lyonnet S, Abadie V.

Prenat Diagn. 2015 Sep;35(9):853-8. doi: 10.1002/pd.4619. Epub 2015 Jun 15.

PMID:
25982360
38.

MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.

Ak G, Tomaszek SC, Kosari F, Metintas M, Jett JR, Metintas S, Yildirim H, Dundar E, Dong J, Aubry MC, Wigle DA, Thomas CF Jr.

Biomed Res Int. 2015;2015:635748. doi: 10.1155/2015/635748. Epub 2015 Feb 1.

39.

Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.

Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Lewis JE, Cassivi SD, Marks RS, Garces YI, Aubry MC.

Am J Surg Pathol. 2015 Apr;39(4):427-41. doi: 10.1097/PAS.0000000000000391.

PMID:
25634747
40.

Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.

Roden AC, Yi ES, Jenkins SM, Edwards KK, Donovan JL, Cassivi SD, Marks RS, Garces YI, Aubry MC.

J Thorac Oncol. 2015 Apr;10(4):691-700. doi: 10.1097/JTO.0000000000000482.

41.

Diagnostic significance of cell kinetic parameters in World Health Organization type A and B3 thymomas and thymic carcinomas.

Roden AC, Yi ES, Jenkins SM, Donovan JL, Cassivi SD, Garces YI, Marks RS, Aubry MC.

Hum Pathol. 2015 Jan;46(1):17-25. doi: 10.1016/j.humpath.2014.10.001. Epub 2014 Oct 14.

PMID:
25455993
42.

Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer.

Murphy SJ, Aubry MC, Harris FR, Halling GC, Johnson SH, Terra S, Drucker TM, Asiedu MK, Kipp BR, Yi ES, Peikert T, Yang P, Vasmatzis G, Wigle DA.

J Clin Oncol. 2014 Dec 20;32(36):4050-8. doi: 10.1200/JCO.2014.56.7644. Epub 2014 Nov 10.

43.

A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321.

Zhao Y, Foster NR, Meyers JP, Thomas SP, Northfelt DW, Rowland KM Jr, Mattar BI, Johnson DB, Molina JR, Mandrekar SJ, Schild SE, Bearden JD 3rd, Aubry MC, Adjei AA.

J Thorac Oncol. 2015 Jan;10(1):172-80. doi: 10.1097/JTO.0000000000000383.

44.

Generation and sequencing of pulmonary carcinoid tumor cell lines.

Asiedu MK, Thomas CF Jr, Tomaszek SC, Peikert T, Sanyal B, Sutor SL, Aubry MC, Li P, Wigle DA.

J Thorac Oncol. 2014 Dec;9(12):1763-71. doi: 10.1097/JTO.0000000000000339.

45.

Chromosomal rearrangements and copy number abnormalities of TP63 correlate with p63 protein expression in lung adenocarcinoma.

Aubry MC, Roden A, Murphy SJ, Vasmatzis G, Johnson SH, Harris FR, Halling G, Knudson RA, Ketterling RP, Feldman AL.

Mod Pathol. 2015 Mar;28(3):359-66. doi: 10.1038/modpathol.2014.118. Epub 2014 Sep 5.

46.

NCCTG N0821 (Alliance): a phase II first-line study of pemetrexed, carboplatin, and bevacizumab in elderly patients with advanced nonsquamous non-small-cell lung cancer with good performance status.

Dy GK, Molina JR, Qi Y, Ansari R, Thomas S, Ross HJ, Soori G, Anderson D, Aubry MC, Meyers J, Adjei AA, Mandrekar S, Adjei AA.

J Thorac Oncol. 2014 Aug;9(8):1146-53. doi: 10.1097/JTO.0000000000000217.

47.

Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies.

Roden AC, Maleszewski JJ, Yi ES, Jenkins SM, Gandhi MJ, Scott JP, Aubry MC.

J Heart Lung Transplant. 2014 Dec;33(12):1223-32. doi: 10.1016/j.healun.2014.06.006. Epub 2014 Jun 18.

PMID:
25149365
48.

Clinical biomarkers of pulmonary carcinoid tumors in never smokers via profiling miRNA and target mRNA.

Deng B, Molina J, Aubry MC, Sun Z, Wang L, Eckloff BW, Vasmatzis G, You M, Wieben ED, Jen J, Wigle DA, Yang P.

Cell Biosci. 2014 Jul 9;4:35. doi: 10.1186/2045-3701-4-35. eCollection 2014.

49.

Smoking-related idiopathic interstitial pneumonia.

Flaherty KR, Fell C, Aubry MC, Brown K, Colby T, Costabel U, Franks TJ, Gross BH, Hansell DM, Kazerooni E, Kim DS, King TE Jr, Kitachi M, Lynch D, Myers J, Nagai S, Nicholson AG, Poletti V, Raghu G, Selman M, Toews G, Travis W, Wells AU, Vassallo R, Martinez FJ.

Eur Respir J. 2014 Sep;44(3):594-602. doi: 10.1183/09031936.00166813. Epub 2014 Jul 25.

50.

Genomic rearrangements define lineage relationships between adjacent lepidic and invasive components in lung adenocarcinoma.

Murphy SJ, Wigle DA, Lima JF, Harris FR, Johnson SH, Halling G, Asiedu MK, Seto CT, Terra S, Kosari F, Peikert T, Yang P, Aubry MC, Vasmatzis G.

Cancer Res. 2014 Jun 1;74(11):3157-67. doi: 10.1158/0008-5472.CAN-13-1727.

Supplemental Content

Loading ...
Support Center